mal peg mal (mw 2000)

DMG-PEG-Mal (MW 2000) is a PEG lipid that enhances the delivery efficiency and tissue specificity of poorly soluble drugs. It is applicable in drug delivery research.

Mal-NH-PEG-NH2 (TFA) (MW 2000) is a PEG derivative potentially used for the thiol PEGylation of protein molecules. The maleimide group (-Mal) degrades in aqueous media and finds application in drug delivery studies.

Mal-PEG-OH (MW 2000) serves as a macromolecular initiator for the ring-opening polymerization of LA to produce amphiphilic diblock copolymers. These amphiphilic block copolymers are used to prepare nanoparticles, forming an active drug delivery system. The nanoparticles can encapsulate Triptolide , addressing its poor water solubility and reducing its toxicity.

DSPE-Hyd-PEG-Mal (MW 2000) is a phospholipid. With excellent biocompatibility and significant amphiphilic properties, phospholipids are ideal as primary formulations or excipients in drug formulations, leading to enhanced therapeutic outcomes. DSPE-Hyd-PEG-Mal (MW 2000) is applicable in drug delivery research.

Mal-PEG-NH2 TFA (MW 2000) is a linear heterobifunctional PEG product containing maleimide and NH2 groups. The maleimide group can react with thiol, SH, mercapto, or sulfhydryl groups, while the amine group can react with carboxylic acids or activated NHS esters.

Mal-PEG-SCM (MW 2000) is a linear heterobifunctional PEG compound that features maleimide and NHS ester (succinimidyl) groups. It serves as a significant PEGylated crosslinker. The maleimide moiety reacts with thiols, SH groups, mercaptans, or sulfhydryls, while SCM stands for succinimidyl carboxymethyl ester, which can interact with primary amines. Maleimide contains a reactive C=C double bond, sensitive to light or oxygen.

6-Arm-PEG-Mal (MW 2000) is a maleimide-modified PEG derivative that forms stable thioether bonds with sulfhydryl (-SH) groups. The PEG modification enhances solubility and stability while reducing the immunogenicity of proteins and peptides.

TPP-PEG-Mal (MW 2000) is a PEG derivative composed of triphenyl phosphate (TPP), PEG units, and maleimide. The maleimide group can form a stable thioether bond with thiol (-SH) groups.

Fmoc-PEG-Maleimide (MW 2000) (Fmoc-NH-PEG-Mal (MW 2000)) is a PEG derivative featuring an Fmoc protecting group and a maleimide reactive group. The Fmoc group acts as a common amino-protecting agent that prevents unwanted reactions until specific coupling is required. Maleimide forms stable thioether bonds with sulfhydryl groups (-SH). PEG modification enhances solubility and stability while reducing the immunogenicity of proteins and peptides.

DBCO-PEG-Maleimide (MW 2000) (DBCO-PEG-Mal (MW 2000)) is a PEG derivative composed of DBCO, PEG units, and Maleimide. The Maleimide moiety forms stable thioether bonds with thiol (-SH) groups. The DBCO group enables the compound to engage in strain-promoted alkyne-azide cycloaddition reactions (SPAAC) with azide-containing molecules.

4-Arm-PEG-Maleimide (MW 2000) (4-Arm-PEG-Mal (MW 2000)) is a PEG derivative modified with Maleimide, which forms stable thioether bonds with sulfhydryl (-SH) groups. PEG modification enhances solubility and stability while reducing the immunogenicity of proteins and peptides.

DMG-PEG-Mal (MW 2000) is a PEG derivative composed of N,N-Dimethylglycine (DMG), PEG segments, and Maleimide. The Maleimide group reacts with thiols (-SH) to create stable thioether bonds. DMG-PEG-Mal (MW 1000) is applicable for drug delivery.

Methoxypolyethylene glycol maleimide (MW 2000) is a reagent used in biochemical reactions.